Publication | Open Access
Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective study
14
Citations
34
References
2021
Year
Serum SEMA4C demonstrated promising potential as a candidate biomarker for breast cancer diagnosis. However, validation in prospective settings and by other study groups is warranted.
| Year | Citations | |
|---|---|---|
Page 1
Page 1